Imidazotriazinones and the use thereof

US7098207B2 · kind B2 · utility

Assignee

• Bayer Pharmaceuticals Corporation · US

Inventors

• Ulrich Niewohner · Wermelskirchen, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Helmut Haning · Milford, US
• Gunter Schmidt · Houghton, US
• Karl-Heinz Schlemmer · Wuppertal, DE
• Erwin Bischoff · Wuppertal, DE
• Klaus Dembowsky · Boston, US
• Elisabeth Perzborn · Wuppertal, DE
• Mazen Es-Sayed · Langenfeld, DE

Key dates

• Filing date: Jan 5, 2005
• Grant date: Aug 29, 2006
• Expiry date: Apr 7, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel imidazotriazinones of general formulaa method for the production and the pharmaceutical use thereof are disclosed.